What is Panacea Biotec Intrinsic Value: Projected FCF?
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2024-05-25), Panacea Biotec's Intrinsic Value: Projected FCF is ₹58.35. The stock price of Panacea Biotec is ₹136.30. Therefore, Panacea Biotec's Price-to-Intrinsic-Value-Projected-FCF of today is 2.3.
The historical rank and industry rank for Panacea Biotec's Intrinsic Value: Projected FCF or its related term are showing as below:
BOM:531349'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.73 Med: 1.47 Max: 11.35
Current: 2.34
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Panacea Biotec was 11.35. The lowest was 0.73. And the median was 1.47.
BOM:531349's Price-to-Projected-FCF is ranked worse than 51.18% of 211
companies
in the Biotechnology industry
Industry Median: 2.31
vs BOM:531349: 2.34
Panacea Biotec Intrinsic Value: Projected FCF Historical Data
The historical data trend for Panacea Biotec's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Panacea Biotec's Intrinsic Value: Projected FCF
For the Biotechnology subindustry, Panacea Biotec's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Biotec's Price-to-Projected-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Panacea Biotec's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Panacea Biotec's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Panacea Biotec's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
136.30
/
58.345886384729
=
2.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Biotec Intrinsic Value: Projected FCF Related Terms
Thank you for viewing the detailed overview of Panacea Biotec's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:531349 has been successfully added to your 